Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer.

Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer.

Item
http://www.wikidata.org/entity/Q41346867
Immunological battlefield in gastric cancer and role of immunotherapiesSTAT1-associated intratumoural TH1 immunity predicts chemotherapy resistance in high-grade serous ovarian cancer.CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy.Immunological Functions of the Omentum.Size matters: Survival benefit conferred by intratumoral T cells is dependent on surgical outcome, treatment sequence and T cell differentiation.Potential role of radiation therapy in augmenting the activity of immunotherapy for gynecologic cancers.Impact of neoadjuvant chemotherapy on the immune microenvironment in advanced epithelial ovarian cancer: Prognostic and therapeutic implications.Systematic analysis reveals a lncRNA-mRNA co-expression network associated with platinum resistance in high-grade serous ovarian cancer.
P2860

Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer.

Item
http://www.wikidata.org/entity/Q41346867
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Treatment Regimen, Surgical Ou ...... h-Grade Serous Ovarian Cancer.
@en
type
label
Treatment Regimen, Surgical Ou ...... h-Grade Serous Ovarian Cancer.
@en
prefLabel
Treatment Regimen, Surgical Ou ...... h-Grade Serous Ovarian Cancer.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Treatment Regimen, Surgical Ou ...... gh-Grade Serous Ovarian Cancer
@en
P2093
P304
P31
P356
10.1158/1078-0432.CCR-15-1617
P407
P433
P478
P50
P577
P698
P921